UBS Group’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-48,752
| Closed | -$13.7K | – | 9380 |
|
2024
Q3 | $13.7K | Buy |
48,752
+17,690
| +57% | +$4.97K | ﹤0.01% | 6367 |
|
2024
Q2 | $23.3K | Buy |
+31,062
| New | +$23.3K | ﹤0.01% | 6056 |
|
2024
Q1 | – | Sell |
-12,113
| Closed | -$9.95K | – | 9001 |
|
2023
Q4 | $9.95K | Buy |
+12,113
| New | +$9.95K | ﹤0.01% | 6254 |
|
2023
Q3 | – | Sell |
-13,814
| Closed | -$20.4K | – | 8910 |
|
2023
Q2 | $20.4K | Buy |
+13,814
| New | +$20.4K | ﹤0.01% | 5785 |
|
2023
Q1 | – | Sell |
-1,239
| Closed | -$2.48K | – | 9585 |
|
2022
Q4 | $2.48K | Buy |
1,239
+1,126
| +996% | +$2.25K | ﹤0.01% | 8472 |
|
2022
Q3 | $1K | Sell |
113
-15
| -12% | -$133 | ﹤0.01% | 9039 |
|
2022
Q2 | $2K | Buy |
+128
| New | +$2K | ﹤0.01% | 8646 |
|
2021
Q2 | – | Sell |
-254
| Closed | -$9K | – | 8736 |
|
2021
Q1 | $9K | Buy |
+254
| New | +$9K | ﹤0.01% | 7003 |
|